Montauk Renewables Inc (MKR)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 3,400.00 |
|---|---|
| 52-week range | 1,701.00 – 5,000.00 |
| Return, 1 month / 3 months | −15.0% / +27.3% |
| Return, 1 year / 3 years | −5.6% / −81.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 94.6% |
| Worst drawdown (1 year) | -56.0% |
| Average daily value traded | 32.79M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Montauk Renewables is a renewable energy company based in Pittsburgh, Pennsylvania, that captures methane gas produced at landfills and turns it into useful energy. The company develops, owns and operates projects that convert landfill gas into renewable natural gas for pipeline injection and into electricity for sale to utilities and other customers. Its operations are concentrated in the United States, where it manages a portfolio of landfill gas recovery facilities serving energy markets and industrial buyers.
Montauk Renewables Inc trades under the code MKR on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Montauk Renewables Inc (MKR) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 3,400.00 on 22 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 123 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.6% and over the last three months it rose 27.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 72 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.2% | ||
| From 52-week high | -32.0% | ||
| Momentum | 83 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 27.3% | ||
| 6-month return | 40.5% | ||
| 12-month return, skipping the last month | 11.1% | ||
| Stability (higher is calmer) | 12 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 94.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -56.0% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 32.79M ZAC | ||
| Zero-volume days | 6.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −15.0% |
| 3 months | +27.3% |
| 6 months | +40.5% |
| 1 year | −5.6% |
| 3 years | −81.8% |
| 5 years | −79.8% |
Signals
| 50-day / 200-day average | 3,694.34 / 2,829.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 427.55 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.